Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Corydalis yanhusuo (Yan Hu Suo) is a traditional Chinese medicinal herb derived from the tuber of the plant Corydalis yanhusuo. It has been used for centuries in Traditional Chinese Medicine (TCM) primarily for its analgesic and blood-invigorating properties. The main active compounds include alkaloids such as tetrahydropalmatine (THP), dehydrocorybulbine, leonticine, tetrahydroberberine, and corydalmine. These constituents are believed to exert their effects by modulating dopamine receptors and stimulating opiate receptors involved in pain management[5][6][7]. Yan Hu Suo is commonly prescribed for various types of pain including chest pain, abdominal pain, dysmenorrhea (painful menstruation), traumatic injuries, and chronic musculoskeletal discomfort[2][4][5]. Modern research suggests it may also have anti-inflammatory effects and could potentially reduce opioid tolerance or dependence by inhibiting dopamine receptor-mediated pathways[6][7]. In TCM practice it is categorized as an herb that invigorates blood flow and moves Qi to alleviate stagnation-related symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corydalis yanhusuo.